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Increased calcium intake is associated
lower serum 25-hydroxyvitamin D levels in
subjects with adequate vitamin D intake: a
population-based observational study
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Abstract
Background: There are indications that an increased intake of calcium has a vitamin D sparing effect, which might
be explained by a decreased catabolism of 25-hydroxyvitamin D (25(OH)D). However, there are only a few studies
where this has been examined.
Method: In the seventh survey of the Tromsø study, serum 25(OH)D and parathyroid hormone were measured, and
questionnaires on calcium and vitamin D intakes filled in.
Results: There were significant interactions between sex, calcium and vitamin D intakes regarding serum 25(OH)D
level. The analyses were therefore done stratified. In males there was, regardless of vitamin D intake, a significant
decrease in serum 25(OH)D with increasing calcium intake. The difference in serum 25(OH)D between those with
the highest and lowest calcium intakes was approximately 10%. In the females, there was in subjects with low
vitamin D intake (< 7 μg/d) a significant increase in serum 25(OH)D with increasing calcium intake, which could not
be explained by secondary hyperparathyroidism. In females with higher vitamin D intakes, increasing calcium intake
was associated with lower serum 25(OH)D levels.
Conclusions: There is, at least in subjects with an adequate vitamin D intake, a negative association between
calcium intake and serum 25(OH)D.
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Background
Vitamin D is obtained from the diet or supplements
and also from production in the skin upon sun expos-
ure. Vitamin D is first hydroxylated in the liver to 25-
hydroxyvitamin D (25(OH)D), and then in the kidneys
to 1,25-dihydroxyvitamin D (1,25(OH)2D) which is the
active form of the vitamin. The main biological effect of 1,
25(OH)2D is to increase the intestinal calcium absorption.
The 25-hydroxylation is substrate driven, whereas the 1-
hydroxylation is tightly regulated by parathyroid hormone
(PTH). If the serum calcium level falls, the serum PTH
level increase stimulating secretion of 1,25(OH)2D and
thereby restoration of the serum calcium level [1].
The serum level of 25(OH)D is generally considered as
the best marker of a subjects vitamin D status, due to its
ease of measurement, long half-life and correlation with
known vitamin D effects. However, there is no
consensus as to what can be considered an adequate or
optimal serum 25(OH)D level [2, 3].
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Vitamin D deficiency may in children lead to rickets
and in adults to osteomalacia. At least for the prevention
of rickets, it appears that a high calcium intake can
compensate for a low vitamin D intake and vice versa
[4]. There are also indications that there might be an
interaction between these intakes, so that a high calcium
intake cause an increase in the serum 25(OH)D level as
reviewed by Heaney [5]. Thus, rats fed a high calcium
diet had a higher serum 25(OH)D level than rats on a
low calcium diet [6], and in rats the inactivation of
25(OH)D in the liver is increased by calcium deprivation
[7]. Furthermore, in subjects with primary or secondary
hyperparathyroidism Davies et al. have shown that the
half-life of 25(OH)D was lower in those with high 1,
25(OH)2D levels. This could be explained by 1,
25(OH)2D inducing the 24-hydroxylase which is the
enzyme starting the degradation process of 25(OH)D as
well as 1,25(OH)2D [8]. Based on these observations the
concept of a vitamin D sparing effect of a high calcium
intake has been suggested [9].
However, observational studies on calcium and vita-
min D intakes regarding serum 25(OH)D levels have
been equivocal. Thus, Olmos et al. found the serum
25(OH)D level to be positively correlated with dairy in-
take in 1811 individuals [10], as did Kinyamu in 243
women [11]. On the other hand, this was not confirmed
by Hill et al. in a group of 1015 adolescents from Northern
Ireland [12] nor by Andersen et al. in a group of 247
Pakistani living in Denmark and with low serum 25(OH)D
levels [13]. Similarly, randomized controlled trials (RCTs)
have shown a large and positive effect by calcium supple-
mentation on the 25(OH)D response to vitamin D supple-
mentation in one study [14], which has not been
confirmed in others [15–18].
In the last Tromsø study serum 25(OH)D was measured
and questionnaires on intakes of vitamin D and calcium
filled in by more than 11,000 subjects. In a sub-group of
1917 subjects serum PTH was measured as well. This gave
us the opportunity to evaluated interrelationships between
these intakes regarding serum 25(OH)D level, and to evalu-
ate if these relationships could be explained by secondary
hyperparathyroidism, which to our knowledge has not been
done in a huge cohort before.
Methods
Study design and participants
The Tromsøs study is a population-based health survey
performed in Tromsø, Northern Norway at 69° North.
The first survey was performed in 1974 and the seventh
survey in 2015/2016. Originally the study focused on
cardiovascular diseases and their prevention, but later
surveys have included a wide range of tests and analyses
[19]. In the seventh survey all citizens older than 40
years and living in the municipality of Tromsø were
invited, and 64.7% (21,083) attended. The subjects filled
in a general health questionnaire including intakes of
vitamin D and calcium supplements, sunny vacation(s)
last two months, and use of solarium. Intakes of vitamin
D and calcium were estimated based on a validated food
frequency questionnaire that included 261 questions on
food items, meals, and beverages [20, 21]. Non-fasting
blood samples were drawn; height and weight were
measured wearing light clothing, and body mass index
(BMI) calculated as kg/m2.
Biochemical analyses
All biochemical analyses were performed at the Depart-
ment of Medical Biochemistry, University Hospital of
North Norway. Serum 25(OH)D was measured in all
subjects and determined by an in-house-developed LC/
MS-MS method as previously described in detail [22].
The laboratory takes part in the external quality pro-
gram DEQAS. Serum PTH and calcium were measured
in a subgroup of 3769 subjects who also had attended
the fourth survey in 1994/1995. Serum PTH was ana-
lysed with an electrochemiluminescence immunoassay
using an automated clinical chemistry analyser (Cobas
6000, Roche). Serum calcium was measured by an auto-
mated analyser (Modular P, Roche Diagnostics, Mannheim,
Germany) with reagents from Boehringer Mannheim.
Reference ranges for serum PTH were 1.1–6.8 pmol/L for
those < 51 years and 1.1–7.5 pmol/L for those > 50 years,
and for serum calcium 2.20–2.50mmol/L.
Statistical analyses
Normal distribution was evaluated by visual inspection
of histograms and by calculation of skewness and cur-
tosis, and considered normal for all dependent variables
except for serum PTH. Serum PTH was therefore nor-
malized by log transformation before use as dependent
variable. Comparisons between groups were performed
with Student’s t-test. For evaluation of predictors of
serum 25(OH)D a linear regression model was used
with covariates as indicated in the table. Interactions
between calcium and vitamin D intake groups, gender
and age regarding the serum 25(OH)D level were evalu-
ated with a general linear model. Linear trends were
evaluated with linear regression with adjustments for
sex, age, BMI and month of blood sampling (with the
use of dummy variables) as indicated in the tables.
All data presented in this study, including the biochem-
ical analyses, are from the seventh survey of the Tromsø
study. The data are shown as mean (95% CI). All tests
were done two-sided, and a P-value < 0.05 was considered
statically significant. The Bonferroni correction for mul-
tiple comparisons was used as indicated in the tables.
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Results
Main study
A total of 13,743 subjects had completed datasets re-
garding vitamin D and calcium intakes and valid serum
25(OH)D measurement. Among these, 2466 had been
on a recent sunny holiday and among the remainder, 27
were using solarium on a regular basis, leaving 11,250
subjects (5982 females and 5268 males) who were in-
cluded in the present analyses. Among these, 6.7% used
calcium tablets daily, and 37.2% used cod liver oil and/or
omega-3 fish oil capsules and/or other supplements with
vitamin D on a daily basis, and 12.7% were daily
smokers. The mean serum 25(OH)D level was 62.2
nmol/L, and 29.6% of the subjects had serum 25(OH)D <
50 nmol/L. Other characteristics are shown in Table 1.
In a linear regression model with serum 25(OH)D as
dependent variable, female gender, age and vitamin D
intake were significant positive predictors of serum
25(OH)D, whereas BMI and calcium intake were signifi-
cant negative predictors (Supplemental Table 1).
However, there was a significant interaction between
calcium and vitamin D intakes regarding 25(OH)D (P <
0.001). Furthermore, when doing this analysis stratified
for vitamin D intake, there was in the lowest vitamin D
intake group (< 7 μg/d) a significant interaction be-
tween sex and calcium intake regarding serum
25(OH)D (P < 0.01). The relations between serum
25(OH)D, vitamin D and calcium intakes were
therefore analysed for all subjects together as well as
sex stratified. There were no interactions with age.
With increasing vitamin D intake there was a signifi-
cant increase in serum 25(OH)D in all calcium intake
groups in both genders. With increasing calcium intake
there was in the low vitamin D intake group (< 7 μg/d) a
significant increase in serum 25(OH)D in the females
but not in the males. In the males and when both gen-
ders were analysed together, there was with increasing
calcium intake a non-significant decrease in serum
25(OH)D in the 7–13.9 μg vitamin D/d intake group,
whereas in the two highest vitamin D intake groups
(14.0–20.9 and > 20.9 μg/d) there was a significant de-
crease in serum 25(OH)D. In these two vitamin D intake
groups the difference in serum 25(OH)D between those
with the lowest and highest calcium intake was ~ 10%
(Table 2 and Figs. 1, 2 and 3).
Sub-group study
A total of 1917 subjects (1089 females and 828 males)
had valid data-sets as above, valid serum PTH measure-
ment and serum calcium < 2.51 nmol/L, and were in-
cluded in the sub-group analyses. Among these, 11.8%
used calcium tablets daily, and 53.2% used cod liver oil
and/or omega-3 fish oil capsules and/or other supple-
ments with vitamin D on a daily basis. Their other
baseline characteristics are shown in Table 1. In general,
Table 1 Characteristics of the participants in the main cohort and the sub-study
All subjects Males Females
Main cohorta
N 11,250 5268 5982
Age (years) 58.3 (58.1, 58.5) 58.5 (58.2, 58.8) 58.0 (57.7, 58.3)*
BMI (kg/m2) 27.3 (27.2, 27.4) 27.7 (27.6, 27.8) 26.9 (26.8, 27.1)***
Serum 25(OH)D (nmol/L) 62.2 (62.0, 62.7) 59.2 (58.7, 59.8) 65.1 (64.5, 65.6)***
Vitamin D intake (ug/d)c 14.1 (14.0, 14.3) 14.5 (14.2, 14.7) 13.9 (13.6, 14.1)**
Calcium intake (mg/d)c 1188 (1177, 1199) 1247 (1231, 1264) 1136 (1121, 1151)***
Sub-studyb
N 1917 828 1089
Age (years) 70.2 (69.8, 70.6) 70.7 (70.3, 71.3) 69.9 (69.3, 70.4)
BMI (kg/m2) 27.4 (27.2, 27.6) 27.6 (27.3, 27.8) 27.4 (27.1, 27.6)
Serum 25(OH)D (nmol/L) 68.2 (67.3, 69.2) 65.3 (64.0, 66.7) 70.4 (69.2, 71.7)***
Serum PTH (pmol/L) 5.8 (5.7, 5.9) 5.9 (5.7, 6.0) 5.8 (5.7, 5.9)
Serum calcium (mmol/L) 2.36 (2.36, 2.36) 2.35 (2.35, 2.36) 2.37 (2.36, 2.37)***
Vitamin D intake (ug/d)c 14.9 (14.4, 15.4) 15.2 (14.5, 15.9) 14.6 (14.0, 15.3)
Calcium intake (mg/d)c 1168 (1140, 1195) 1199 (1157, 1241) 1144 (1108, 1181)
*P < 0.05, **P < 0.01, ***P < 0.001. Student’s t-test versus males
a Subjects in the Tromsø study with valid food frequency questionnaires, serum 25(OH) D measurement, not been on a sunny vacation last 2 months, and not
taking solarium regularly
b As in the main cohort but with valid serum PTH measurement and with serum calcium < 2.51 mmol/L
cIncluding supplements
The data are mean (95% CI). The P values are not adjusted for multiple testing
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these subjects were older and had higher serum
25(OH)D levels than those in the main cohort.
As expected the serum PTH levels were highest in the
subjects with the lowest calcium and vitamin D intakes.
However, this was only significant for a few of the
vitamin D and calcium intake subgroups (Table 3). As in
the main study there was in the females a significant
(P < 0.001) increase in serum 25(OH)D with increasing
calcium intake in those with a low vitamin D intake,
whereas there in both genders was a decrease in serum
25(OH)D with increasing calcium intake in those with
higher vitamin D intakes (Table 4). The same pattern
was seen if dividing the cohort in subjects with serum
PTH below or above 5.35 pmol/L (the median PTH level),
which is illustrated for the females in Figs. 4 and 5.
Discussion
In the present study we have found a negative associ-
ation between calcium intake and serum 25(OH)D,
except in females with a low vitamin D intake where the
association was positive. Furthermore, these associations
were seen in subjects with low as well as high serum
PTH levels.
Our results are at difference with previous observa-
tional studies on calcium intake and serum 25(OH)D
[14–18]. There are two likely explanations for this.
Firstly, there was an interaction between calcium and
vitamin D intakes as well as between genders regarding
serum 25(OH)D, and analysing the cohorts without
proper stratification as in our study could possibly mask
the true relations. Furthermore, the difference in serum
25(OH)D level between those with high and low calcium
intakes was approximately 10%, and accordingly, a large
number of subjects need to be included, as in our study,
to show significant effects.
It is difficult to find a plausible explanation for the
mainly negative association between calcium intake and
serum 25(OH)D. One could hypothesize that in a



















Vitamin D intake (ug/d)§
< 7.0 444 56.2 (54.3, 58.0) 1396 54.8 (53.8, 56.7) 874 56.7 (55.2, 58.1) 302 56.7 (54.3, 59.1)
7.0–13.9 223 60.8 (58.1, 63.5) 1360 60.8 (59.8, 61.9) 1531 59.7 (58.7, 60.6) 943 57.8 (56.5, 59.0)#
14.0–20.9 69 69.1 (64.0, 74.1) 513 69.0 (67.3, 70.8) 624 66.6 (65.0, 68.2) 553 62.5 (60.8, 64.2)#**
> 20.9 77 76.2 (71.1, 81.2)† 666 74.3 (72.7, 76.0)† 871 72.5 (71.2, 73.8)† 804 69.6 (68.2, 71.1)#**†
Males‡
Vitamin D intake (ug/d)§
< 7.0 165 54.5 (51.7, 57.3) 530 52.3 (50.7, 53.9) 363 52.3 (50.3, 54.2) 139 49.8 (47.1, 52.6)
7.0–13.9 93 57.3 (53.0, 61.6) 635 57.3 (55.8, 58.8) 815 56.8 (55.6, 58.1) 536 54.4 (52.8, 56.0)
14.0–20.9 29 62.5 (57.4, 67.7) 208 66.6 (63.7, 69.5) 284 62.6 (60.5, 64.7) 321 59.0 (56.9, 61.1)#**
> 20.9 32 77.7 (68.9, 86.5)† 286 72.3 (69.9, 74.6)† 401 70.5 (68.7, 72.4)† 431 65.9 (64.1, 67.7)#**†
Females‡
Vitamin D intake (ug/d)§
< 7.0 279 57.2 (54.7, 59.7) 866 56.4 (55.0, 57.7) 511 59.8 (57.8, 61.8) 163 62.6 (59.1, 66.2)#*
7.0–13.9 130 63.4 (59.9, 66.8) 725 64.0 (62.5, 65.5) 716 62.9 (61.5, 64.4) 407 62.2 (60.4, 64.1)
14.0–20.9 40 73.9 (66.2, 81.6) 305 70.7 (68.5, 73.0) 340 70.0 (67.6, 72.3) 232 67.4 (64.6, 70.2)
> 20.9 45 75.1 (68.9, 81.4)† 380 75.9 (73.7, 78.1)† 470 74.2 (72.4, 76.0)† 373 73.9 (71.8, 76.1)†
#P < 0.01. Linear trend for serum 25(OH)D across calcium intake groups without adjustments
*P < 0.05, **P < 0.01. Linear trend for serum 25(OH)D across calcium intake groups with sex, age, BMI and month of blood sampling (using dummy variables)
as covariates
†P < 0.001. Linear trend for serum 25(OH)D across vitamin D intake groups without adjustments as well as with sex, age, BMI and month of blood sampling (using
dummy variables) as covariates
‡ Subjects in the Tromsø study with valid food frequency questionnaires, serum 25(OH)D measurement, not been on a sunny vacation last 2 months, and not
taking solarium regularly
§Including supplements
The data are mean (95% CI). The P values are adjusted for multiple testing with a factor of 4
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situation with a low calcium intake it would be import-
ant for the body to conserve its 25(OH)D stores and
therefore reduce the 24-hydroxylation of 25(OH)D to
the inactive 24,25(OH)2D form. However, low
calcium intake and thereby low serum calcium levels
stimulate the PTH secretion which increases the
renal 1-hydroxylation of 25(OH)D to the active form 1,
25(OH)2D which in turn increases the intestinal calcium
absorption. This process cause removal of 25(OH)D from
the circulation. Additionally, 1,25(OH)2D activates the 24-
hydroxylase which starts the degradation and thus the
elimination of 25(OH)D [1]. One would therefore expect
that a low calcium intake should reduce, and not increase
the serum 25(OH)D level. These PTH related mechanisms
could therefore theoretically offer an explanation for the
positive association between calcium intake and serum
25(OH)D in the females with low vitamin D intake. How-
ever, since the same patters of relation between calcium
intake and serum 25(OH)D were seen when stratifying
these females according to serum PTH levels, this cannot
be the explanation.
The main calcium source is dairy products and
subjects with a high calcium intake therefore also have
a high phosphate intake, which will trigger the secre-
tion of fibroblast growth factor 23 (FGF23). FGF23 will
reduce the intestinal phosphate absorption by reducing
the 1,25(OH)2D level through increased catabolism of
1,25(OH)2D as well as 25(OH)D [23]. Unfortunately
we did not measure serum FGF23 nor serum phos-
phate and this explanation therefore purely speculative.
Another explanation could be that the absorption of
vitamin D was reduced by a high calcium intake which
thereby would be associated with a lower serum
25(OH)D level. The absorption of vitamin D is as-
sumed to be through passive diffusion as well as by
membrane carriers, and may be increased by concomi-
tant fat ingestion [24]. Furthermore, intestinal calcium
ingestion may, by the formation of calcium-fatty acid
soaps, which are excreted in the faeces, cause a slight
reduction in intestinal fat absorption [25]. However,
this reduction is less than 5 g/d [26], which is probably
too low to significantly affect the vitamin D absorption
Fig. 1 Serum 25(OH)D in relation to vitamin D and calcium intakes
in 11,250 subjects who have not been on a sunny vacation last two
months, and not taking solarium regularly
Fig. 2 Serum 25(OH)D in relation to vitamin D and calcium intakes
in 5268 males who have not been on a sunny vacation last two
months, and not taking solarium regularly
Fig. 3 Serum 25(OH)D in relation to vitamin D and calcium intakes
in 5982 females who have not been on a sunny vacation last two
months, and not taking solarium regularly
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and can therefore hardly explain our findings. Add-
itionally, we have no plausible hypotheses for why the
positive association between calcium intake and serum
25(OH)D in subjects with low vitamin D intake was
seen in women only, since there was no major gender
differences regarding calcium and vitamin D intakes,
age, BMI and PTH. If our findings are not the results
of unaccounted for confounding, we therefore have to
postulate the existence of unknown physiological
process that regulate the vitamin D metabolism in re-
sponse to calcium intake. In this regard the concept of
the personal vitamin D response index should be con-
sidered [27]. According to this concept, the molecular
response to supplementation with vitamin D, such as
changes in the epigenetic status and the respective
transcription of genes, varies considerably between in-
dividuals. Hence, the measured serum 25(OH)D may
not necessarily reflect the true impact of vitamin D
and calcium supplementation on vitamin D metabol-
ism in a given individual.
Our study was purely observational and we can
therefore not imply causality between calcium intake
and the serum 25(OH)D level. This has to be tested
in randomized controlled trials (RCTs) for which
there are only a few relevant ones. Thus, in a study
by Goussous et al., 52 subjects were given 800 IU
vitamin D/d and randomized to 500 mg calcium twice
daily or placebo for 90 days. In the calcium group the
mean serum 25(OH)D increased 16.2 nmol/L versus
17.4 nmol/L in the control group [16]. Similarly, in a
study by McCullough et al. 92 subjects were random-
ized to 800 IU vitamin D/d, 2000 mg calcium, both or
placebo for 6 months. The increase in serum
25(OH)D was almost identical, 25 and 26 nmol/L re-
spectively, in those with and without additional cal-
cium [17]. In a study by Grant et al. on prevention of
low trauma fractures, 5292 subjects were randomized
to 800 IU vitamin D/d, 1000 mg calcium/d, both or
placebo, and serum 25(OH)D measured before and
after one year in a subgroup of 60 subjects. In those
allocated to combined vitamin D and calcium, serum
25(OH)D rose by 24.0 nmol/L, whereas the increase
in those given vitamin D alone was 24.3 nmol/L [18].
And finally, in a study by Cashman et al. including









n Serum PTH (pmol/L) n Serum PTH (pmol/L) n Serum PTH (pmol/L) n Serum PTH (pmol/L)
All subjects‡
Vitamin D intake (ug/d)§
< 7.0 86 6.3 (5.8, 6.9) 230 5.9 (5.6, 6.2) 125 5.8 (5.5, 6.2) 53 5.7 (5.0, 6.5)
7.0–13.9 44 6.6 (5.7, 7.4) 225 5.9 (5.7, 6.2) 236 5.9 (5.6, 6.1) 119 6.0 (5.6, 6.4)
14.0–20.9 15 7.4 (5.0, 9.8) 85 5.8 (5.4, 6.3) 130 5.6 (5.3, 6.0) 104 5.8 (5.3, 6.2)
> 20.9 16 5.7 (4.5, 6.9) 143 5.7 (5.4, 6.1) 151 5.4 (5.0, 5.9) 155 5.3 (5.1, 5.6)
Males‡
Vitamin D intake (ug/d)§
< 7.0 28 6.9 (5.6, 8.2) 92 5.8 (5.4, 6.2) 44 5.8 (5.2, 6.5) 19 5.9 (4.4, 7.5)
7.0–13.9 21 7.0 (5.4, 8.6) 103 6.1 (5.6, 6.6) 107 6.0 (5.6, 6.4) 66 6.1 (5.6, 6.7)
14.0–20.9 4 5.7 (4.4, 6.9) 33 5.6 (4.9, 6.4) 56 5.6 (5.0, 6.2) 50 6.1 (5.4, 6.8)
> 20.9 4 5.7 (1.2, 9.5) 68 5.6 (5.2, 6.0) 62 5.6 (4.5, 6.7) 71 5.2 (4.9, 5.6)†
Females‡
Vitamin D intake (ug/d)§
< 7.0 58 6.1 (5.6, 6.6) 138 6.0 (5.6, 6.4) 81 5.8 (5.4, 6.2) 34 5.6 (4.7, 6.5)
7.0–13.9 23 6.1 (5.3, 6.9) 122 5.8 (5.5, 6.1) 129 5.8 (5.4, 6,2) 53 5.8 (5.2, 6.4)
14.0–20.9 11 8.0 (4.7, 11.4) 52 6.0 (5.3, 6.6) 74 5.7 (5.3, 6.1) 54 5.4 (5.0, 5.9)#
> 20.9 12 5.7 (4.2, 7.2) 75 5.8 (5.3, 6.3) 89 5.3 (5.0, 5.7) 84 5.4 (5.0, 5.8)
#P < 0.05. Linear trend for serum PTH across calcium intake groups without adjustments
†P < 0.05. Linear trend for serum PTH across vitamin D intake groups without adjustments as well as with sex, age, BMI and month of blood sampling (using
dummy variables) as covariates
‡ Subjects in the Tromsø study with valid food frequency questionnaires, serum 25(OH)D measurement, not been on a sunny vacation last 2 months, not taking
solarium regularly, with valid serum PTH measurement, and with serum calcium < 2.51 mmol/L.
§ Including supplements
The data are mean (95% CI). The P values are adjusted for multiple testing with a factor of 4
Jorde and Grimnes BMC Nutrition            (2020) 6:49 Page 6 of 9
125 subjects stratified according to calcium intake
and given 800 IU vitamin D/d, there was no evidence
of a 25(OH)D sparing effect of high calcium intake. How-
ever, in the subjects with a low calcium intake (< 700mg/
d) the increase in mean serum 25(OH)D was non-
significantly higher than in those with a high calcium in-
take (> 1000mg/d) (26.1 nmol/L vs 20.0 nmol/l) [15].
All of these studies have included relatively few sub-
jects. Given that the effect probably is small and may
be different in subgroups, larger studies are needed to
settle this question. It is unlikely that a large RCT will
be designed specifically for this purpose, but there is at
least one large study performed with vitamin D inter-
vention with or without additional calcium and with
serum 25(OH)D measurements. Thus, in the study by
Baron et al. 2259 participants with recently diagnosed
adenomas and no known colorectal polyps remaining
after colonoscopy, were assigned to vitamin D 1000 IU/
d, calcium 1200 mg/d, both or neither, with recurrence
of adenoma as primary endpoint. Serum 25(OH)D was
measured at baseline and after 1 year. However, the
serum 25(OH)D increase in the vitamin D alone vs the
vitamin D plus calcium groups was not (as far as we
have been able to find) specifically reported in their
publications [28].
Our study has several limitations. Firstly, as an ob-
servational study we cannot conclude about causality.
We did not measure serum 1,25(OH)2D and 24,
25(OH)2D, nor did we do gene-expression studies,
which would have been important from a mechanistic-
ally point of view. Our subjects had a mean age of 58
years and only 29.6% were vitamin D deficient (serum
25(OH)D < 50 nmol/L). Our results are therefore not
relevant for children at risk of rickets. Although our
study was population based, the subjects in the sub-
study were highly selected with mean age ~ 70 years
and with mean serum 25(OH)D as high as 70 nmol/L.
On the other hand, our study also has strengths as we
included a large number of subjects, which made it
meaningful to do stratified analyses. The observation


















Vitamin D intake (ug/d)§
< 7.0 86 59.4 (55.4, 63.5) 230 60.4 (57.9, 62.9) 125 63.8 (60.2, 67.4) 53 69.3 (62.2, 76.4)##*
7.0–13.9 44 61.7 (55.3, 68.1) 225 66.2 (63.4, 69.1) 236 66.2 (63.6, 68.8) 119 65.3 (62.0, 68.6)
14.0–20.9 15 81.6 (70.3, 92.8) 85 75.1 (69.9, 80.2) 130 71.2 (67.7, 74.7) 104 67.8 (64.1, 71.4)#*
> 20.9 16 81.1 (68.0, 94.2)† 143 74.5 (71.3, 77.6)† 151 76.6 (73.5, 79.8)† 155 75.4 (72.4, 78.5)†
Males‡
Vitamin D intake (ug/d)§
< 7.0 28 58.7 (51.2, 65.5) 92 59.4 (55.7, 63.1) 44 57.8 (53.1, 62.6) 19 54.6 (45.9, 63.2)
7.0–13.9 21 56.6 (46.6, 66.6) 103 63.3 (59.4, 67.1) 107 63.8 (60.0, 67.6) 66 61.8 (57.4, 66.2)
14.0–20.9 4 76.6 (50.1, 103.0) 33 74.4 (64.2, 84.6) 56 67.1 (62.4, 71.8) 50 61.6 (56.3, 66.9)#*
> 20.9 4 81.8 (35.2, 128.5) 68 75.7 (70.6, 80.8)† 62 75.2 (70.9, 79.4)† 71 71.0 (67.3, 74.7)†
Females‡
Vitamin D intake (ug/d)§
< 7.0 58 59.8 (54.6, 64.9) 138 61.1 (57.8, 64.4) 81 67.1 (62.2, 71.9) 34 77.5 (68.5, 86.6)##**
7.0–13.9 23 66.3 (58.0, 74.7) 122 68.7 (64.6, 72.8) 129 68.2 (64.7, 71.7) 53 69.7 (64.7, 74.7)
14.0–20.9 11 83.4 (68.7, 98.1) 52 75.5 (69.7, 81.2) 74 74.3 (69.3, 79.3) 54 73.4 (68.7, 78.2)
> 20.9 12 80.9 (65.4, 96.3)† 75 73.3 (69.4, 77.3)† 89 77.7 (73.2, 82.2)† 84 79.2 (74.6, 83.7)
#P < 0.05, ## < 0.01. Linear trend for serum 25(OH)D across calcium D intake groups without adjustments
*P < 0.05, **P < 0.01. Linear trend for serum 25(OH)D across calcium intake groups with sex, age, BMI and month of blood sampling (using dummy variables)
as covariates
†P < 0.001. Linear trend for serum 25(OH)D across vitamin D intake groups without adjustments as well as with sex, age, BMI and month of blood sampling (using
dummy variables) as covariates
‡ Subjects in the Tromsø study with valid food frequency questionnaires, serum 25(OH)D measurement, not been on a sunny vacation last 2 months, not taking
solarium regularly, with valid serum PTH measurement, and with serum calcium < 2.51 mmol/L
§ Including supplements
The data are mean (95% CI). The P values are adjusted for multiple testing with a factor of 4
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of a negative association between calcium intake and
serum 25(OH)D, at least in subjects with adequate
vitamin D intake, was statistically highly significant
and might reflect unknown aspects of vitamin D metabol-
ism. Direct or indirect inhibition of 25-hydroxylation and/
or stimulation of 25(OH)D degradation by calcium are the
most obvious pathways, that potentially could be verified
by gene-expression studies.
Conclusions
We have found serum 25(OH)D to decrease with
increasing calcium intake, at least in subjects with an
adequate intake of vitamin D. Our findings are hard to
explain, but if confirmed in large intervention trials,
studies aiming at explaining the underling mechanisms
should be encouraged.
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